| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $215.5M | +11.6% |
| Cost of Revenue | $15.4M | +94.1% |
| R&D Expense | $50.5M | +42.7% |
| SG&A Expense | $125.1M | +28.4% |
| Operating Income | -$69.6M | -751.3% |
| Pre-tax Income | $96.4M | -36.4% |
| Income Tax | $179.1M | — |
| Net Income | -$116.0M | -292.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $17.4M | -0.6% |
| Current Assets | $55.0M | -44.4% |
| Total Assets | $199.0M | -45.5% |
| Current Liabilities | $46.3M | +22.5% |
| Total Liabilities | $84.3M | -63.9% |
| Stockholders' Equity | $13.4M | -78.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.6M | -150.3% |
| Capital Expenditures | $16.1M | +102.3% |
| Investing Cash Flow | -$17.8M | +41.6% |
| Financing Cash Flow | -$9.8M | -117.8% |
| Free Cash Flow | -$27.7M | -282.6% |